{"id":"W4403410377","doi":"10.1016/j.jtho.2024.09.074","title":"OA14.05 KRAS G12C Inhibitor IBI351 In Patients (pts) with Advanced Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Pivotal Phase 2 Study","year":2024,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Samsung; Genentech; Humanitas Research Hospital; Universitair Ziekenhuis Antwerpen; Jewish General Hospital; Maastricht Universitair Medisch Centrum; Peter MacCallum Cancer Centre; Sungkyunkwan University; University of Manchester; Victoria University; University of Melbourne; Ottawa Hospital Research Institute; Monash University; Università degli Studi di Milano; Hospital de Câncer de Barretos; Seoul National University; Seoul National University Bundang Hospital; McGill University; Yale Cancer Center; Yale University","keywords":"Medicine; KRAS; Lung cancer; Oncology; Internal medicine; Phases of clinical research; Cancer; Cancer research; Clinical trial; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006202036,0.0002977766,0.0009579488,0.0007186692,0.00005900652,0.00004534878,0.0001546734,0.0001862112,0.0003074792],"category_scores_gemma":[0.00009938712,0.0002126596,0.0002230663,0.0008107279,0.00006527612,0.000257343,0.0000590684,0.0009760861,0.00002548307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008042652,"about_ca_system_score_gemma":0.0009416544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001664623,"about_ca_topic_score_gemma":0.0005116167,"domain_scores_codex":[0.9971803,0.0002705763,0.001234048,0.0004392721,0.0005146623,0.0003611561],"domain_scores_gemma":[0.998179,0.0001729849,0.0006285897,0.0002590174,0.0004395442,0.0003208891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1531743,0.06410472,0.1364993,0.0008288669,0.005373203,0.04784766,0.02467127,0.001533235,0.0886946,0.000003396582,0.07121373,0.4060557],"study_design_scores_gemma":[0.364586,0.1546442,0.222867,0.03710051,0.02027294,0.00112012,0.02657212,0.0263389,0.09037347,0.0001013847,0.05216476,0.003858539],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957865,0.0004228273,0.0001309075,0.001640707,0.0004699208,0.0005799443,0.0001655946,0.00003436788,0.000769164],"genre_scores_gemma":[0.997007,0.00004623644,0.001073073,0.0004878703,0.0005983686,0.00002108434,0.0001115176,0.00004281376,0.0006120384],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4021972,"threshold_uncertainty_score":0.8672006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01272044977152004,"score_gpt":0.3825332284158667,"score_spread":0.3698127786443466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}